4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0001209191-23-011782
Chief Executive Officer gave up 6,373 shares (to pay taxes)
- Chief Executive Officer acquired 13,250 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kulkarni Samarth Chief Executive Officer | 2023-02-18 | Option exercise | +13,250 | 382,361 | D | ||
| Kulkarni Samarth Chief Executive Officer | 2023-02-21 | Shares withheld for taxes | −6,373 | $48.26 | $307,561 | 375,988 | D |
| Derivatives | |||||||
| Kulkarni Samarth Chief Executive Officer | 2023-02-18 | Option exercise · Restricted Stock Units | −13,250 | 39,750 | D | ||
Loading xslF345X03/doc4.xml…